ChemoMetec A/S (CHEMM)

Currency in DKK
502.50
-9.00(-1.76%)
Closed·
CHEMM Scorecard
Full Analysis
Impressive gross profit margins
CHEMM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
501.00513.50
52 wk Range
332.40616.00
Key Statistics
Prev. Close
511.5
Open
512.5
Day's Range
501-513.5
52 wk Range
332.4-616
Volume
12.46K
Average Volume (3m)
31.27K
1-Year Change
38.24%
Book Value / Share
34.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CHEMM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
598.33
Upside
+19.07%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

ChemoMetec A/S News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

ChemoMetec A/S Company Profile

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

Employees
184
Market
Denmark

Compare CHEMM to Peers and Sector

Metrics to compare
CHEMM
Peers
Sector
Relationship
P/E Ratio
52.6x29.5x−0.5x
PEG Ratio
2.97−1.040.00
Price/Book
14.9x3.6x2.6x
Price / LTM Sales
19.4x4.2x3.2x
Upside (Analyst Target)
25.1%23.3%42.0%
Fair Value Upside
Unlock4.0%6.6%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 598.33
(+19.07% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 9.72%
Dividend Yield
0.78%
Industry Median 2.84%
Annualised payout
4.00
Paid annually
5-Years Growth
-11.81%
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
3.64 / 3.17
Revenue / Forecast
124.00M / 115.00M
EPS Revisions
Last 90 days

CHEMM Income Statement

People Also Watch

1,463.5
GMAB
-0.24%
1,537.5
DSV
-0.71%
325.0
NOVOb
-6.31%
879.60
EVOG
+0.25%
235.10
TCFP
-0.34%

FAQ

What Stock Exchange Does ChemoMetec Trade On?

ChemoMetec is listed and trades on the Copenhagen Stock Exchange stock exchange.

What Is the Stock Symbol for ChemoMetec?

The stock symbol for ChemoMetec is "CHEMM."

What Is the ChemoMetec Market Cap?

As of today, ChemoMetec market cap is 8.73B.

What Is ChemoMetec's Earnings Per Share (TTM)?

The ChemoMetec EPS (TTM) is 9.72.

When Is the Next ChemoMetec Earnings Date?

ChemoMetec will release its next earnings report on 10 Sept 2025.

From a Technical Analysis Perspective, Is CHEMM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ChemoMetec Stock Split?

ChemoMetec has split 0 times.

How Many Employees Does ChemoMetec Have?

ChemoMetec has 184 employees.

What is the current trading status of ChemoMetec (CHEMM)?

As of 30 Jul 2025, ChemoMetec (CHEMM) is trading at a price of 502.50, with a previous close of 511.50. The stock has fluctuated within a day range of 501.00 to 513.50, while its 52-week range spans from 332.40 to 616.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.